These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 34260978)

  • 1. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study.
    Fukihara J; Sakamoto K; Ikeyama Y; Furukawa T; Teramachi R; Kataoka K; Kondoh Y; Hashimoto N; Ishii M
    Respir Res; 2024 May; 25(1):202. PubMed ID: 38730452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveolar lavage differential cell count on prognostic assessment of patients with stable or acute interstitial lung disease: A retrospective real-life study.
    Salonen J; Lampela H; Keskitalo E; Vähänikkilä H; Purokivi M; Kaarteenaho R
    Clin Immunol; 2020 Nov; 220():108594. PubMed ID: 32927080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
    Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
    Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia.
    Takei R; Arita M; Kumagai S; Ito Y; Noyama M; Tokioka F; Ishida T
    BMC Pulm Med; 2017 Apr; 17(1):67. PubMed ID: 28427425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease.
    Watase M; Mochimaru T; Kawase H; Shinohara H; Sagawa S; Ikeda T; Yagi S; Yamamura H; Matsuyama E; Kaji M; Kurihara M; Sato M; Horiuchi K; Watanabe R; Nukaga S; Irisa K; Satomi R; Oyamada Y
    PLoS One; 2023; 18(3):e0283288. PubMed ID: 36930615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
    Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
    Domagała-Kulawik J
    Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
    Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
    PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in acute exacerbation of fibrosing interstitial lung disease: an individualized treatment protocol based on microbiological evidence.
    Zhan S; Li S; Cao Y; Liu D; Feng J
    BMC Pulm Med; 2024 Aug; 24(1):400. PubMed ID: 39164677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
    Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
    PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
    Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
    Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
    Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?
    Domagała-Kulawik J; Skirecki T; Maskey-Warzechowska M; Grubek-Jaworska H; Chazan R
    Inflammation; 2012 Jun; 35(3):803-9. PubMed ID: 21882075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.